A Phase 1 Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-Dose Gemcitabine in Metastatic Pancreatic Adenocarcinoma Patients

Saved in:

Bibliographic Details
Published in	Clinical cancer research Vol. 29; no. 24; pp. 5047 - 5056
Main Authors	Huffman, Brandon M., Feng, Hanrong, Parmar, Kalindi, Wang, Junning, Kapner, Kevin S., Kochupurakkal, Bose, Martignetti, David B., Sadatrezaei, Golbahar, Abrams, Thomas A., Biller, Leah H., Giannakis, Marios, Ng, Kimmie, Patel, Anuj K., Perez, Kimberly J., Singh, Harshabad, Rubinson, Douglas A., Schlechter, Benjamin L., Andrews, Elizabeth, Hannigan, Alison M., Dunwell, Stanley, Getchell, Zoe, Raghavan, Srivatsan, Wolpin, Brian M., Fortier, Caroline, D’Andrea, Alan D., Aguirre, Andrew J., Shapiro, Geoffrey I., Cleary, James M.
Format	Journal Article
Language	English
Published	15.12.2023
Online Access	Get full text

Loading…

More Information
Bibliography:	These authors are co-senior authors.
ISSN:	1078-0432 1557-3265
DOI:	10.1158/1078-0432.CCR-23-2005